Key facts
- It has raised $42.7M; the latest was Later Stage VC ($10.0M) in Feb 2026.
- Notable investors include Wasatch Health.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Stratus Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Stratus Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Stratus Medical
Developer of medical devices designed to offer advanced radiofrequency ablation treatment for chronic pain. The company's device is a minimally invasive multitined expandable radiofrequency electrode that is used to treat chronic pain, with an optimally shaped large volume lesion and delivers good value for clinicians, patients and facilities with faster procedure times, lower cost and predictable and durable pain relief, enabling doctors to reduce pain suffering in chronic pain patients.
- Sector
- Healthcare
- HQ
- Magnolia, TX, United States
- Founded
- 2019
- Employees
- 24
- Website
- stratusmedical.com/
- Ownership
- Privately Held (backing)
Stratus Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Stratus Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Stratus Medical in its N-PORT filings yet. We sweep new filings monthly.